S
SRZN
Surrozen Inc
29.69
+1.72+6.15%After Hours: 29.55 -0.14 -0.47%19:30 10/09 EDT
OPEN/PREV CLOSE27.86/27.97
TODAY RANGE27.53-30.97
VOL781.38K
MARKET CAP348.96M
52 WEEK RANGE11.39-37.83
AVG VOL (3M)493.27K
% TURNOVER6.38%
TURNOVER--
P/E (TTM)-0.8296
% RANGE12.23%
EPS(TTM)-35.7874
P/E(FORWARD)-4.2324
P/B-1.5959
BVPS-18.6035
DIVIDEND--
P/S83.47
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP322.89M
SHARES OUTSTANDING11.75M
NEXT EARNINGS--
FREE FLOAT10.88M
LOT SIZE1
EX-DATE12/14/2023
News
Press Releases
Financial Reports
Profile
NASDAQ·10/02 12:51
Surrozen's SZN-8141 IND Cleared By FDA For Diabetic Macular Edema
Seeking Alpha·10/02 12:45
Surrozen advances diabetic macular edema candidate into clinic after IND clearance
TipRanks·10/02 12:27
Surrozen Wins FDA IND Clearance for SZN-8141 Program
TipRanks·10/02 12:10
Surrozen announces FDA clearance of IND application for SZN-8141
Dow Jones·09/25 12:04
Surrozen Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·09/25 12:04
Surrozen Price Target Raised to $54.00/Share From $44.00 by HC Wainwright & Co.
Benzinga·09/25 12:03
Scholastic Posts Downbeat Q1 Results, Joins Legacy Education, Zscaler And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
Benzinga·09/25 11:52
HC Wainwright & Co. Maintains Buy on Surrozen, Raises Price Target to $54
TipRanks·09/25 10:10
Surrozen price target raised to $54 from $44 at H.C. Wainwright
Benzinga·09/25 08:40
Why INLIF Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Benzinga·09/24 17:06
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·09/24 15:41
Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy
Benzinga·09/24 13:43
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000